931-68-0

Usage

Physical State

Colorless liquid

Solubility

Insoluble in water, soluble in organic solvents

Uses

a. Precursor in the production of other chemicals
b. Solvent in various industrial processes
c. Pesticide
d. Corrosion inhibitor

Toxicity

Toxic if ingested

Potential Hazards

May cause skin and eye irritation upon contact

Safety Precautions

Proper handling and storage required to prevent potential harm

InChI:InChI=1/C7H13Cl/c1-6-2-4-7(8)5-3-6/h6-7H,2-5H2,1H3

Upstream product

• 589-91-3 p-methylcyclohexanol 
• 7731-29-5 trans-4-methylcyclohexan-1-ol 
• 7647-01-0 hydrogenchloride 
• 591-47-9 4-methylcyclohexene 
• 7646-78-8 tin(IV) chloride 

Downstream Products

• 934-67-8 trans-4-methylcyclohexanecarboxylic acid 
• 220203-23-6 trans-4-(4-methylcyclohexyl)-4-oxobutanoic acid 

Relevant academic research and scientific papers

THERAPEUTIC AGENT FOR DIABETES

A therapeutic agent for diabetes, which comprises a compound of the formula [I] wherein Xis a group of the formula wherein R4and R5are the same or different and each is a hydrogen atom, an optionally substituted alkyl having 1 to 5 carbon atoms and the like, and R6is a hydrogen atom or an amino-protecting group; R1is an optionally substituted alkyl having 1 to 5 carbon atoms, an optionally substituted alkenyl having 2 to 6 carbon atoms and the like, R2is a hydrogen atom, an optionally substituted alkyl having 1 to 5 carbon atoms and the like, R2' is a hydrogen atom, and R3is an optionally substituted alkyl having 1 to 5 carbon atoms and the like, a prodrug thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof and a solvate thereof. The compound of the present invention shows superior blood sugar decreasing action on the state of hyperglycemia, but does not affect the blood sugar when it is in the normal range or in the hypoglycemic state, which means that it is free of serious side effects such as hypoglycemia. Therefore, the compound of the present invention is useful as a therapeutic drug for diabetes and also useful as a preventive of the chronic complications of diabetes.

Conformational Studies of Dicyclohexylthallium Chloride, Bis(4-methylcyclohexyl)thallium Chloride and Bis(4-tert-butylcyclohexyl)thallium Chloride by (1)H NMR

Vicinal thallium-hydrogen coupling constants are used to discuss conformations in dicyclohexylthallium chloride, bis(4-methylcyclohexyl)thallium chloride and bis(4-tert-butylcyclohexyl)thallium chloride.Thallium does not have a very strong preference for equatorial positions in dicyclohexylthallium chloride, whereas bis(4-alkylcyclohexyl)thallium chlorides exist largely in one conformation.Bis(4-methylcyclohexyl)thallium chloride exists in three isomeric forms; the major product appears to be the cis-isomer (equatorial methyl, axial thallium), with the other twoisomers probably containing thallium trans to the methyl group (axial thallium being preferred).The preference for the cis-isomer (equatorial tert-butyl, axial thallium) of bis(4-tert-butylcyclohexyl)thallium chloride is such that other isomers are not obtained.